- Home
- KTTA vs POLA Comparison
KTTA vs POLA Comparison
Compare KTTA & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- POLA
- Stock Information
- Founded
- KTTA 2020
- POLA 1979
- Country
- KTTA United States
- POLA United States
- Employees
- KTTA N/A
- POLA N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- POLA Industrial Machinery/Components
- Sector
- KTTA Health Care
- POLA Miscellaneous
- Exchange
- KTTA Nasdaq
- POLA Nasdaq
- Market Cap
- KTTA 5.1M
- POLA 5.2M
- IPO Year
- KTTA 2021
- POLA 2016
- Fundamental
- Price
- KTTA $0.80
- POLA $2.89
- Analyst Decision
- KTTA
- POLA
- Analyst Count
- KTTA 0
- POLA 0
- Target Price
- KTTA N/A
- POLA N/A
- AVG Volume (30 Days)
- KTTA 171.7K
- POLA 844.1K
- Earning Date
- KTTA 08-14-2025
- POLA 08-14-2025
- Dividend Yield
- KTTA N/A
- POLA N/A
- EPS Growth
- KTTA N/A
- POLA N/A
- EPS
- KTTA N/A
- POLA N/A
- Revenue
- KTTA N/A
- POLA $11,967,000.00
- Revenue This Year
- KTTA N/A
- POLA N/A
- Revenue Next Year
- KTTA N/A
- POLA N/A
- P/E Ratio
- KTTA N/A
- POLA N/A
- Revenue Growth
- KTTA N/A
- POLA 0.14
- 52 Week Low
- KTTA $0.65
- POLA $1.53
- 52 Week High
- KTTA $7.50
- POLA $4.69
- Technical
- Relative Strength Index (RSI)
- KTTA 55.44
- POLA 75.63
- Support Level
- KTTA $0.75
- POLA $2.03
- Resistance Level
- KTTA $0.91
- POLA $2.45
- Average True Range (ATR)
- KTTA 0.06
- POLA 0.27
- MACD
- KTTA 0.02
- POLA 0.08
- Stochastic Oscillator
- KTTA 52.10
- POLA 58.73
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.